KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Divestments (2017 - 2025)

Bausch Health Companies (BHC) has disclosed Divestments for 10 consecutive years, with $7.0 million as the latest value for Q3 2025.

  • Quarterly Divestments rose 40.0% to $7.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $7.0 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $7.0 million for FY2025, 0.0% changed from the prior year.
  • Divestments hit $7.0 million in Q3 2025 for Bausch Health Companies, up from $5.0 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $740.0 million in Q1 2021 to a low of $1.0 million in Q2 2023.
  • Historically, Divestments has averaged $156.4 million across 5 years, with a median of $5.0 million in 2022.
  • Biggest five-year swings in Divestments: skyrocketed 3423.81% in 2021 and later changed 0.0% in 2024.
  • Year by year, Divestments stood at $644.0 million in 2021, then tumbled by 99.22% to $5.0 million in 2022, then fell by 20.0% to $4.0 million in 2023, then rose by 25.0% to $5.0 million in 2024, then skyrocketed by 40.0% to $7.0 million in 2025.
  • Business Quant data shows Divestments for BHC at $7.0 million in Q3 2025, $5.0 million in Q3 2024, and $1.0 million in Q2 2024.